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Prevention of transplant 
arteriosclerosis by ex vivo-expanded 
human regulatory T cells
Nadig et al., Nat Med advance online publication, 16 May 2010, doi:10.1038/
nm.2154
Thymus-derived and antigen-induced regulatory T cells (Treg 
cells), initially identified as CD25+CD4+, are well known to pos-
sess potent suppressive capabilities and hold therapeutic promise 
in the regulation of autoimmunity, allergy, and immune-mediated 
transplant rejection. Transplanted organs frequently fail because 
proliferation of vascular smooth muscle cells leads to lumen nar-
rowing and ischemia, a process termed transplant arteriosclerosis. 
The mechanisms responsible for transplant arteriosclerosis are not 
fully clear, but it is likely part of the immune rejection response 
and mediated, at least in part, by interferon-γ (IFN-γ) secreted by 
alloreactive T cells. Studies previously found that allogenic periph-
eral blood mononuclear cells (PBMCs) elicited immune-mediated 
rejection of transplanted human arteries, mimicking the transplant 
arteriosclerosis seen in human transplantation. Importantly, IFN-γ 
elicited the same response in the absence of leukocytes, suggesting 
that both immune and nonimmune mechanisms contribute to the 
disease. In a recent publication, Nadig et al. examined the possibility 
of attenuating the vascular fibro-proliferative lesions seen in trans-
planted organs by using Treg cells. They FACS-sorted human Treg 
cells from healthy donor PBMCs into CD25hi or CD127loCD25+ 
cells (designated CD127lo), which were next expanded more than 
600-fold in vitro. The expanded Treg populations could be frozen 
for storage without loss of functional activity and exerted their sup-
pressive ability over human leukocyte antigen-mismatched PBMCs. 
To obtain a model of transplant arteriosclerosis, human internal 
mammary arterial side branches were transplanted into the aortas 
of BALB/c Rag2−/−;Il2rg−/− mice, which are deficient in T, B, and 
NK cells. Then, mice were inoculated with allogenic or autologous 
PBMCs, and in the former, the researchers found significant vascu-
lar intimal hyperplasia and decreased luminal diameter. Next, they 
reconstituted the mice transplanted with human vessels with human 
PBMCs and ex vivo-expanded CD25hi or CD127lo cells from the 
same allogenic blood donor and found that both the CD25hi and the 
CD127lo populations had a significant impact on the development 
of transplant arteriosclerosis in vivo. The vasculopathy seen in mice 
treated with CD25hi Treg cells was significantly less than that of mice 
not given Treg cells, but mice treated with CD127
lo, ex vivo-expanded 
Treg cells showed almost complete abrogation of transplant arterio-
sclerosis (Figure). As expected, Treg cells had the ability to inhibit 
the secretion of IFN-γ in vivo, which is thought to be integral to the 
development of transplant arteriosclerosis. This study demonstrates 
the ability of ex vivo-expanded human Treg cells to successfully abro-
gate the development of transplant arteriosclerosis in vivo. 
Juan Oliver
A novel K+ secretory renal channel
Carrisoza-Gaytan et al., Am J Physiol Renal Physiol advance online publication, 
28 April 2010, doi:10.1152/ajprenal.00697.2009
Kv1.3 is a voltage-gated potassium channel (Kv) found in many 
organs, including the kidney. Its activation results in outward K+ 
currents that, in neurons, suppress excitability and, in non-excitable 
cells, contribute to stabilization of the resting membrane potential. 
Kv1.3 participates in multiple functions, including apoptosis, cell-
volume regulation, T-cell stimulation, and glucose homeostasis. 
Kv1.3 activity is upregulated by the serum-glucocorticoid-activated 
kinase, one of the main mediators of aldosterone’s action. For tech-
nical reasons, K+ secretion in the distal nephron has been stud-
ied mainly in the cortical collecting duct (CCD), where it is well 
established that K+ secretion under basal conditions is mediated 
mainly by the ROMK inwardly rectifying K+ channels and by the 
Ca2+- and voltage-dependent maxi-K channels, which contribute 
to flow-dependent K secretion. Because patients with Bartter’s syn-
drome due to loss of function of ROMK as well as ROMK knock-
out mice show net K+ secretion in the urine, K secretion has been 
attributed to the maxi-K channel. However, specific inhibitors of the 
maxi-K channel failed to completely inhibit urinary K+ excretion in 
ROMK knockout mice, suggesting the presence of other K+ secre-
tory pathways. Previous studies found the Kv1.3 channel in cultures 
of inner medullary collecting duct cells and in the inner medulla 
of the rat kidney. To examine the channel’s role in K+ homeostasis, 
Carrisoza-Gaytan et al. changed the K+ content in the diet of rats 
and found that the channel’s mRNA and protein expression in the 
kidney did not change when dietary K+ was increased from control 
(CK, 1.2% wt/wt) to high K+ (HK, 10% wt/wt). However, dietary K+ 
loading provoked a change in the cellular distribution of Kv1.3 from 
Ex vivo-expanded CD127lo Treg cells decreased development of 
vasculopathy (right) in comparison with transplanted mice inoculated 
with PBMCs alone (left).
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Kv1.3 staining of collecting ducts was intracellular under a control-K 
diet (left), and a high-K diet provoked the trafficking of Kv1.3 to apical 
membranes (right).
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the cytoplasm to apical membranes (Figure). Immunolocalization 
of Kv1.3 detected the channel exclusively in the intercalated cells. 
In addition, Kv1.3 protein was upregulated in plasma membrane 
fractions from the kidney cortex, outer medulla, and inner medulla 
by an HK diet. In perfusion experiments, the authors found that 
Kv1.3 is a secretory channel during high dietary K+. Whereas K+ 
secretion in the CCDs of rats fed a CK diet was not affected by 
a specific Kv1.3 channel blocker, K+ secretion during an HK diet 
was markedly increased and was significantly inhibited by channel 
blockade. These results provide evidence that Kv1.3 channels par-
ticipate in K+ secretion and that apical membrane localization of 
Kv1.3 is enhanced in the intercalated cells by dietary K+ loading.
Juan Oliver
The associations of fibroblast 
growth factor 23 and uncarboxy-
lated matrix Gla protein with 
mortality in coronary artery disease: 
the Heart and Soul Study
Parker et al., Ann Intern Med 2010; 152: 640–648
Vascular calcification is associated with morbidity and mortal-
ity in patients with chronic kidney disease (CKD) and end-stage 
renal disease (ESRD). Three regulators of mineral metabolism 
mediate this risk. Fibroblast growth factor 23 (FGF23) promotes 
renal phosphorus wasting and inhibits the conversion of vitamin 
D to its 1,25-dihydroxy form. Matrix Gla protein prevents arterial 
calcification through local effects in the vessel wall, while fetuin-A 
prevents the precipitation of calcium and phosphorus in the serum. 
The Heart and Soul Study uses an observational cohort of outpa-
tients with a history of cardiac disease. Fasting serum samples were 
drawn at baseline, and patients were followed with annual telephone 
interviews. Both FGF23 and matrix Gla protein were associated 
with increased risk of mortality. Patients with the highest values of 
FGF23 and those with the lowest values of matrix Gla protein expe-
rienced the highest rates of mortality and cardiovascular events. 
In multivariable models, these associations were significant when 
adjusted for age, sex, and ethnicity and remained significant, though 
attenuated, when factors such as calcium, phosphorus, C-reactive 
protein, and glomerular filtration rate were included in the model. 
Importantly, the association between both of these biomarkers and 
increased risk of events did not vary on the basis of the presence or 
absence of CKD defined as an estimated glomerular filtration rate 
of less than 60 ml per minute. While levels of fetuin-A are associated 
with an increased risk of mortality in patients with ESRD, in this 
study, no association between fetuin-A and mortality was demon-
strated in patients with CKD.
These results add to a growing number of associations identified 
first in patients with CKD and then generalizable to a larger, more 
population-based group of patients. Associations between serum 
phosphorus levels, parathyroid hormone levels, inflammation, and 
altitude first identified in patients with CKD have subsequently 
been established in patients irrespective of kidney function. If the 
relationship between serum phosphorus and intermediate mark-
ers such as FGF23 that is present in patients with kidney disease is 
absent in a patient without kidney disease, the potential for more 
complex triggers of FGF23 secretion may be in play. Therefore, a 
detailed understanding of how these relationships are manifested 
among those without kidney disease proves essential.
Lynda Szczech
Induction of diabetes in aged C57B6 
mice results in severe nephropathy: 
an association with oxidative 
stress, endoplasmic reticulum 
stress, and inflammation
Wu et al., Am J Pathol 2010; 176: 2163–2176; doi:10.2353/ajpath.2010.090386
Only 30–40% of patients with diabetes mellitus (DM) eventually 
develop diabetic nephropathy. Therefore, the elucidation of genetic 
and environmental factors influencing the development of dia-
betic nephropathy remains a major area of research. Mouse models 
have been helpful in pointing toward genetic and dietary factors 
favoring diabetic nephropathy. For example, the C57BL6 mouse 
strain is considered to be almost resistant to the development of 
diabetic renal disease, whereas the db/db genetic background is 
susceptible to DM nephropathy. The reasons for the differences 
in susceptibility are considered to be genetic, though the exact 
genetic variants remain to be defined at present.1 Now, Wu et al. 
report that the relative resistance of the C57BL6 mouse strain may 
relate to oxidative stress, as it can be overcome in aged mice with 
lower tolerance for cell stress. A slowly progressive process, kidney 
aging is postulated to be accelerated by intervening diseases, such 
as diabetes, in part because of the addition of excessive stress and 
inflammation from such diseases to the underlying aging process. 
The researchers tested this hypothesis by inducing diabetes with 
streptozotocin in 18-month-old, aging mice. Surprisingly, after 
only 4 months of diabetes, these aging C57BL6 mice developed 
severe albuminuria, elevated creatinine levels, and renal lesions 
including extensive apoptotic cell death, glomerulosclerosis, affer-
ent and efferent hyalinosis, and tubulointerstitial inflammation and 
fibrosis, findings considered typical for diabetic nephropathy. This 
was associated with evidence for elevated oxidative stress, such as 
endoplasmic reticulum (ER) stress with upregulation of C/EBP 
homologous protein (CHOP). The ER stress may play a role in 
increasing kidney lesions, as CHOP-deficient mice were protected 
from diabetic nephropathy.
Taken together, these results may indicate that the relative resis-
tance of the C57BL6 mouse strain to the development of diabetic 
renal disease may relate to differences in the development of or 
susceptibility to oxidative stress. Furthermore, the studies sup-
port the hypothesis that diabetes may accelerate aging processes in 
the kidney, which may in turn favor the development of diabetic 
nephropathy.
Detlef Schlöndorff 
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